10 results
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology Summary ... agent • Does not cause ... mL/minute/1.73 m2 ... #Pharmacology #Summary ... #DM2 #diabetes
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... GLP-1 receptor agonists ... EricsMedicalLectures/featured #diabetes ... endocrinology #dm2
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... relative with DM2 ... Hypertension, Overweight, Abdominal ... • Secondary Causes ... Management #algorithm #DM2
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology Summary ... mL/minute/1.73 m2 ... diabetic ketoacidosis ... #Pharmacology #Summary ... #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology Summary ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... GLP-I receptor agonist ... not definitively cause ... #Pharmacology #Summary ... #DM2 #diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... GLP-1 receptor agonist ... insulin in Type 1 Diabetes ... #Mellitus #DM2
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
and Management Summary ... Insulin resist + DM ... peripheral (bronchial/abdominal ... Pegvisomant) ± D2 ... agonist (Carbergoline
Stiff Person Syndrome (SPS) - Diagnosis and Management Summary

Epidemiology:
 • Prevalence: 1-2 cases per million -
and Management Summary ... Prevalence: 1-2 cases ... associated with DM ... contractions (agonist
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... Intraabdominal - Orthopedic ... Diabetes regimen ... undergoing AAA or upper abdominal